We propose to study host-parasite interactions in Leishmaniasis, with the long range goal of identifying parasite antigens which could be used in a vaccine. The importance of these studies derives not only from the public health significance of leishmaniasis to certain developing countries, but also as an excellent model for understanding the immunology and cell-biology of intracellular infections generally. We will test our hypothesis (based upon compelling preliminary observations) that Leishmania attach to mononuclear phagocytes via fibronectin (FN) absorbed on their surface. We will attempt to identify FN on the parasites by 1) surface iodination followed by immunoprecipitation with anti-FN antibody and SDS-PAGE; 2) immunofluorescence with specific anti-FN antibody; and 3) immune electron microscopy. We will seek evidence for a FN receptor by measuring 125I-FN binding to parasites and binding of parasites to FN-coated surfaces. We will prevent binding of parasites to monocytes and other cells with anti-FN antibody, exogenous FN, and by removal of FN receptors. Studies will be initiated to isolate a FN receptor from promastigotes. Cell-mediated immunity will be studied by examining the ability of draining lymph node lymphocytes to induce leishmanistatic/'cidal mechanisms in L. tropica infected macrophages in vitro. Variables to be assessed include antigen specificity, genetic restriction, and identification of effector cell phenotype. We will develop monoclonal antibodies to identify antigens recognized in this reaction by blocking effector cell function in vitro. Subsequent isolation and purification of these antigens could be used in a vaccine.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI017151-06
Application #
3127002
Study Section
(SSS)
Project Start
1980-07-01
Project End
1988-02-29
Budget Start
1986-04-01
Budget End
1988-02-29
Support Year
6
Fiscal Year
1986
Total Cost
Indirect Cost
Name
Tufts University
Department
Type
Schools of Medicine
DUNS #
604483045
City
Boston
State
MA
Country
United States
Zip Code
02111
Sypek, J P; Jacobson, S; Vorys, A et al. (1993) Comparison of gamma interferon, tumor necrosis factor, and direct cell contact in activation of antimycobacterial defense in murine macrophages. Infect Immun 61:3901-6
Birkland, T P; Sypek, J P; Wyler, D J (1992) Soluble TNF and membrane TNF expressed on CD4+ T lymphocytes differ in their ability to activate macrophage antileishmanial defense. J Leukoc Biol 51:296-9
Sypek, J P; Matzilevich, M M; Wyler, D J (1991) Th2 lymphocyte clone can activate macrophage antileishmanial defense by a lymphokine-independent mechanism in vitro and can augment parasite attrition in vivo. Cell Immunol 133:178-86
Sypek, J P; Wyler, D J (1991) Antileishmanial defense in macrophages triggered by tumor necrosis factor expressed on CD4+ T lymphocyte plasma membrane. J Exp Med 174:755-9
Sypek, J P; Wyler, D J (1990) T-cell hybridomas reveal two distinct mechanisms of antileishmanial defense. Infect Immun 58:1146-52
Sypek, J P; Wyler, D J (1988) Susceptibility of lymphokine-resistant Leishmania to cell contact-mediated macrophage activation. J Infect Dis 158:392-7
Wyler, D J (1987) Fibronectin in parasitic diseases. Rev Infect Dis 9 Suppl 4:S391-9
North, T W; Wyler, D J (1987) DNA synthesis in promastigotes of Leishmania major and L. donovani. Mol Biochem Parasitol 22:215-21
Wyler, D J; Beller, D I; Sypek, J P (1987) Macrophage activation for antileishmanial defense by an apparently novel mechanism. J Immunol 138:1246-9
Crawford, G D; Wyler, D J; Dinarello, C A (1985) Parasite-monocyte interactions in human leishmaniasis: production of interleukin-1 in vitro. J Infect Dis 152:315-22

Showing the most recent 10 out of 13 publications